MannKind (MNKD) AFREZZA Phase 3s Met Primary Endpoints in Type 1 & 2 Diabetes
Tweet Send to a Friend
MannKind Corporation (Nasdaq: MNKD) announced that it will hold a conference call at 4:00 pm (EDT) today to discuss preliminary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
